|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 40012 | Randomised Phase III Intergroup Trial in Resected Stage 2 (Dukes B) Colon Cancer : 6-month Infusional 5FU-CPT11 (+/- Folinic Acid) versus Observation. Determination of Biologic Predictive and Response Factors (PETACC-4). |
| 40023 | Multicentre, double-blind, placebo-controlled randomised phase III study of adjuvant therapy with celecoxib in combination with chemotherapy in patients with curatively resected stage III colon cancer (PETACC-5). |
| 40001 | Randomized study of pre-operative radio-chemotherapy versus surgery alone in thoracic oesophageal cancer deemed to be resectable |
| 05011 | Time finding study of chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer. |
| 05991 | A phase II study of chronomodulated preoperative infusional chemoradiation for biliary tract cancer |
| 22011 | Continuous fluorouracil plus mitomycin C versus mitomycin C plus Cisplatin as chemotherapy combination in combined radiochemotherapy for locally advanced anal cancer. A phase II-III study. |
| 30012 | A Randomised Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs Interferon-alpha Alone in Patients with Advanced Renal Cell Carcinoma. |
| 40954 | Randomized phase III study of preoperative chemotherapy followed by surgery versus surgery alone in locally advanced gastric cancer (cT3 and cT4NxM0). |
| 40963 | Pan-European Trial in Adjuvant Colon Cancer- PETACC-2 Randomised phase III intergroup trial of high-dose infusional 5-FU (+ or - Folinic Acid) versus Standard bolus 5-FU/Folinic Acid. |
| 40004 | CLOCC trial (Chemotherapy + Local ablation versus Chemotherapy). Randomized phase II study investigating the role of local treatment of liver metastases by radiofrequency combined with chemotherapy and of chemotherapy alone in patients with unresectable colorectal liver metastases. |
| 10995 | A Phase II Study of CMF in Combination with Anti c-erbB2 antibody (HerceptinR) in Women with c-erbB2 positive Metastatic Breast Cancer |
| 10994 | First prospective Intergroup Translational Research Trial assessing the potential predictive value of p53 using a functional assay in yeast in patients with locally advanced/inflammatory or large operable breast cancer prospectively randomised to a taxane versus a non taxane regimen. |
| 40071 | Effectiveness of first line treatment with lapatinib and ECF/X in histologically proven adenocarcinoma of the stomach or the esophagogastric junction, metastatic or not amenable to curative surgery according to HER2 and EGFR status: a randomized phase II trial. |
| 10054 | A phase I-II study of Lapatinib and Docetaxel as neoadjuvant treatment for locally advanced breast cancer. |
| 10041 | MINDACT (Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid Chemo Therapy): A prospective, randomized study comparing the 70-gene signature with the common clinicpathological criteria in selecting patients for adjuvant chemotherapy in breast cancer with 0 to 3 positive nodes" |
| 24061 | Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategies |
| 24051 | Phase I/II study on induction chemotherapy followed by chemoradiation with or without lapatinib, a dual EGFR/ErbB2 kinase inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell. |
| 40051 | Randomized phase II trial evaluating the feasibility and tolerance of the combination of FOLFOX with cetuximab and the combination of FOLFOX with cetuximab and bevacizumab as perioperative treatment in patients with resectable liver metastases from colorectal cancer (BOS). |
| 16029 | Phase I study of PS-341 (VELCADE)in combination with 5FU/LV plus oxaliplatin in patients with advanced colorectal cancer |